Big Pharma和Biotech共同面临的困境：全球制药进入一个少产品的时代
Time：
2023-09-01 09:20
Author：
孟八一
当科济牵手Moderna：CLDN18.2靶点上，CAR-T疗法能否突破实体瘤？
Time：
2023-08-25 09:04
Author：
xieyijun
写意报告 | 当过冬可能成为常态，Biotech人才内驱力如何激发？
本文系吕筱在“第四届全球生物医药前沿技术大会”上做报告整理。
Time：
2023-08-24 09:15
Author：
xieyijun
Recommended content
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务